Evaluation of the Effectiveness of a Community Health Management Program for Dry Eye Disease in M… (NCT06443554) | Clinical Trial Compass
UnknownNot Applicable
Evaluation of the Effectiveness of a Community Health Management Program for Dry Eye Disease in Middle-Aged and Elderly Individuals
China182 participantsStarted 2024-02-01
Plain-language summary
This study evaluates the effectiveness of a community health management program for middle-aged and elderly patients with dry eye disease (DED). By comparing the community-based health management plan with conventional treatment, the study aims to determine the impact on eye health and quality of life.
Who can participate
Age range
45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients meeting the diagnostic criteria for dry eye disease.
. Middle-aged and elderly individuals aged 45 years and above.
. Normal cognitive and expressive abilities.
. Informed consent and ability to complete the survey.
. Voluntary participation in the study.
Exclusion criteria
. Patients with other ocular surface diseases, including stye, trachoma, allergic conjunctivitis, etc.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Goal Attainment Scaling (GAS)
Timeframe: 12 weeks
2
Ocular Surface Disease Index (OSDI)
Timeframe: 12 weeks
3
Schirmer I Test
Timeframe: 12 weeks
4
Quality of Life for Dry Eye Patients
Timeframe: 12 weeks
Trial details
NCT IDNCT06443554
SponsorFujian University of Traditional Chinese Medicine